| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.27 | 0.06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |